Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity

Cancer Research

Volumn 60, Issue 1, 2000, Pages 114-120

  Fujii, Hiroaki ^a   Yoshida, Manabu ^a   Gong, Zhu Xue ^a   Matsumoto, Toshiharu ^a   Hamano, Yoshitomo ^a   Fukunaga, Masaharu ^b   Hruban, Ralph H ^c   Gabrielson, Edward ^c   Shirai, Toshikazu ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOSARCOMA; CHROMOSOME LOSS; CHROMOSOME MARKER; CLINICAL ARTICLE; CLONE; FEMALE; GENETIC HETEROGENEITY; GYNECOLOGIC CANCER; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL;

CARCINOSARCOMA; DISEASE PROGRESSION; FALLOPIAN TUBE NEOPLASMS; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; OVARIAN NEOPLASMS; PHENOTYPE; UTERINE NEOPLASMS; VARIATION (GENETICS);

EID: 0033958685     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Gompel, S., and Silverberg, S. G. Pathology in gynecology and obstetrics, Ed. 3, pp. 249-260. Philadelphia: J. B. Lippincott, 1985.
2. Silverberg, S. G., Major, F. J., Blessing, J. A., Fetter, B., Askin, F. B., Liao, S-Y., and Miller, A. Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus: a Gynecologic Oncology Group pathologic study of 203 cases. Int. J. Gynecol. Pathol., 9: 1-19, 1990.
3. Silverberg, S. G. Mixed Müllerian tumors. Curr. Top. Pathol., 85: 35-56, 1992.
4. Schweizer, W., Demopoulos, R., Beller, U., and Dubin, N. Prognostic factors for malignant mixed Müllerian tumors of the uterus. Int. J. Gynecol. Pathol., 9: 129-136, 1990.
5. Sartori, E., Bazzurini, L., Gadducci, A., Landoni, F., Lissoni, A., Maggino, T., Zola, P., and La Face, B. Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study. Gynecol. Oncol., 67: 70-75, 1997.
6. Meyer, R. Mischgeschwülste des Uterus die komplizieretern tumoren. In: F. Henke and O. Lubarsch (eds.), Handbuch der Speziellen Pathologischen Anatomie und Histologie, pp. 412-415. Berlin: Julius Springer, 1930.
7. Gorstein, F., and Anderson, T. L. Malignant mixed mesodermal tumors: carcinoma, sarcoma or both? Hum. Pathol., 22: 207-209, 1991.
8. Wick, M. R., Swanson, P. E. Carcinosarcomas. Current perspectives and historical review of nosological concepts. Semin. Diagn. Pathol., 10: 118-127, 1993.
9. Colombi, R. P. Sarcomatoid carcinomas of the female genital tract (malignant mixed Müllerian tumors). Semin. Diagn. Pathol., 10: 169-175, 1993.
10. Masuda, A., Takeda, A., Fukami, H., Yamada, C., and Matsuyama, M. Characteristics of cell lines established from a mixed mesodermal tumor of the human ovary. Carcinomatous cells are changeable to sarcomatous cells. Cancer (Phila.), 60: 2696-2703, 1987.
11. Emoto, M., Iwasaki, H., Kikuchi, M., Ishiguro, M., Kubota, T., Izumi, H., Shirakawa, K., and Kaneko, Y. Two cell lines established from mixed Müllerian tumors of the uterus. Morphologic, immunocytochemical, and cytogenetic analyses. Cancer (Phila.), 69: 1759-1768, 1992.
12. Emoto, M., Iwasaki, H., Kikuchi, M., and Shirakawa, K. Characteristics of cloned cells of mixed Mullerian tumor of the human uterus. Cancer (Phila.), 71: 3065-3075, 1993.
13. Gorai, I., Doi, C., and Minaguchi, H. Establishment and characterization of carcinosarcoma cell line of the human uterus. Cancer (Phila.), 71: 775-786, 1993.
14. Bitterman, P., Chun, B., and Kurman, R. J. The significance of epithelial differentiation in mixed mesodermal tumors of the uterus: a clinicopathologic and immunohistochemical study. Am. J. Surg. Pathol., 14: 317-328, 1990.
15. Meis, J. M., and Lawrence, W. D. The immunohistochemical profile of malignant mixed Mullerian tumor. Overlap with endometrial adenocarcinoma. Am. J. Clin. Pathol., 94: 1-7, 1990.
16. Costa, M. J., Khan, R., and Judd, R. Carcinosarcoma (malignant mixed Müllerian [mesodermal] tumor) of the uterus and ovary. Arch. Pathol. Lab. Med., 115: 583-590, 1991.
17. George, E., Manivel, J. C., Dehner, L. P., and Wick, M. R. Malignant mixed Mullerian tumors: an immunohistochemical study of 47 cases with histogenetic considerations and clinical correlation. Hum. Pathol., 22: 215-223, 1991.
18. De Brito, P. A., Silverberg, S. G., and Orenstein, J. M. Carcinosarcoma (malignant mixed Müllerian [mesodermal] tumor )of the female genital tract: immunohistochemical and ultrastructural analysis of 28 cases. Hum. Pathol., 24: 132-142, 1993.
19. Mayall, F., Rutty, K., Campbell, F., and Goddard, H. p53 immunostaining suggests that uterine carcinosarcomas are monoclonal. Histopathology, 24: 211-214, 1994.
20. Costa, M. J., Vogelsang, J., and Young L. J. T. p53 gene mutation in female genital tract carcinosarcomas (malignant mixed Müllerian tumors): a clinicopathologic study of 74 cases. Mod. Pathol., 7: 619-627, 1994.
21. Thompson, L., Chang, B., and Barsky, S. H. Monoclonal origins of malignant mixed tumors (carcinosarcomas): evidence for a divergent histogenesis. Am. J. Surg. Pathol., 20: 277-285, 1996.
22. Abeln, E. C. A., Smit, V. T. H. B. M., Wessels, J. W., De Leeuw, W. J. F., Cornelisse, C. J., and Fleuren, G. J. Molecular genetic evidence for the conversion hypothesis of the origin of malignant mixed Mullerian tumors. J. Pathol., 183: 424-431. 1997.
23. Wada, H., Enomoto, T., Fujita, M., Yoshino, K., Nakashima, R., Kurachi, H., Haba, T., Wakasa, K., Shroyer, K. R., Tsujimoto, M., Hongyo, T., Nomura, T., and Murata, Y. Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors. Cancer Res., 57: 5379-5385, 1997.
24. Knounelis, S., Jones, M. W., Papadaki, H., Bakker, A., Swalsky, P., and Finkelstein S. D. Carcinosarcomas (malignant mixed Mullerian tumors) of the female genital tract: comparative molecular analysis of epithelial and mesenchymal components. Hum. Pathol., 29: 82-87, 1998.
25. Fujii, H., Marsh, C., Cairns, P., Sidransky, D., and Gabrielson, E. Genetic divergence in the clonal evolution of breast cancer. Cancer Res., 50; 1493-1497, 1996.
26. Fujii, H., Szumel, R., Marsh, C., Zhou, W., and Gabrielson, E. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast. Cancer Res., 56: 5260-5265, 1996.
27. Boland, C. R., Sato, J., Appelman, H. D., Bresalier, R. S., and Feinberg, A. P. Microallelotyping defines the sequence and tempo of allelic losses at tumor suppressor gene loci during colorectal cancer progression. Nat. Med., 1: 902-909.
28. Shibata, D., Navidi, W., Salovaara, R., Li, Z-H., and Aaltonen, L. A. Somatic microsatellite mutations as molecular tumor clocks. Nat. Med., 2: 676-681, 1996.
29. Fujii, H., Inagaki, M., Kasai, S., Miyokawa, N., Tokusashi, Y., Gabrielson, E., and Hruban, R. H. Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas. Am. J. Pathol., 151: 1447-1454, 1997.
30. Macintosh, C. A., Stower, M., Reid, N., and Maitland, N. J. Precise microdissection of human prostate cancers reveals genotypic heterogeneity. Cancer Res., 58: 23-28, 1998.
31. Jovanovic, A. S., Boynton, K. A., and Mutter, G. L. Uteri of women with endometrial carcinoma contain a histopathological spectrum of monoclonal putative precancers, some with microsatellite instability. Cancer Res., 15: 1917-1921, 1996.
32. Mutter, G. L., Boynton, K. A., Faquin, W. C., Ruiz, R. E., and Jovanovic, A. S. Allelotype mapping of unstable microsatellites establishes direct lineage continuity between endometrial precancers and cancer. Cancer Res., 56: 4483-4486, 1996.
33. Weidner, N., and Zekan, P. Carcinosarcoma of the colon. Report of a unique case with light and immunohistochemical studies. Cancer (Phila.), 58: 1126-1130, 1986.
34. Santeusanio, G., Pascal, R. R., Bisceglia, M., Costantino, A. M., and Bosman, C. Metaplastic breast carcinoma with epithelial phenotype of pseudosarcomatous components. Arch. Pathol. Lab. Med., 112: 82-85, 1988.
35. Pitts, W. C., Rojas, V. A., Gaffey, M. J., Rouse, R. V., Esteban, J., Frierson, H. F., Kempson, R. L., and Weiss, L. M. Carcinomas with metaplasia and sarcomas of the breast. Am. J. Clin. Pathol., 95: 623-632, 1991.
36. Ro, J. Y., Ayala, A. G., Sella, A., Samuels, M. L., and Swanson, D. A. Sarcomatoid renal cell carcinoma: clinicopathologic study of 42 cases. Cancer (Phila.), 59: 516-526, 1987.
37. Young, R. H. Carcinosarcoma of the urinary bladder. Cancer (Phila.), 59: 1333-1339, 1987.
38. Sreenan, J. J., and Hart, W. R. Carcinosarcomas of the female genital tract. A pathologic study of 29 metastatic tumors: further evidence for the dominant role of the epithelial component and the conversion theory of histogenesis. Am. J. Surg. Pathol., 19: 666-674, 1995.
39. Mascasaet, M. A., Waxman, M., Fruchter, R. G., Boyce, J., Hong, P., Nicastri, A. D., and Remy, J. C. Prognostic factors in malignant mesodermal (Müllerian) mixed tumors of the uterus. Gynecol. Oncol., 20: 32-42, 1985.
40. Liu, F-S., Kohler, M. F., Marks, J. R., Bast, R. C., Jr., Boyd, J., and Berchuck, A. Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas. Obstet. Gynecol., 83: 118-124, 1994.
41. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S. H., Giovanella, B. C., Ittmann, M., Tycko, B., Hibshoosh, H., Wingler, M. H., and Parsons, R. PTEN a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science (Washington DC), 275: 1943-1947, 1997.
42. Tashiro, H., Blazes, M. S., Wu, R., Cho, K. R., Bose, S., Wang, S. I., Li, J., Parsons, R., and Ellenson, L. H. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res., 57: 3935-3940, 1997.
43. Risinger, J. I., Hayes, A. K., Berchuck, A., and Barrett, J. C. PTEN/MMACl mutations in endometrial cancers. Cancer Res., 57: 4736-4738, 1997.
44. Virchow, R. Die Krankhaften gerschwuste, Vol. 2, pp. 181-182. Berlin, Germany: Hischward, 1869.